MedTrace Logo

Clinical Evaluation of LifeScan Blood Glucose Monitoring Systems

NCT03920085 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2020-02-28

No results posted yet for this study

Summary

Study to determine the performance of the LifeScan BGMS when conducted at MAC clinical site.

Conditions

Interventions

DEVICE

OneTouch Verio

OneTouch Verio Blood Glucose Monitoring System.

DEVICE

OneTouch Select Plus

OneTouch Select Plus Blood Glucose Monitoring System.

DEVICE

OneTouch Ultra

OneTouch Ultra Blood Glucose Monitoring System.

Sponsors & Collaborators

  • MAC Clinical Research

    collaborator OTHER

  • LifeScan Scotland Ltd

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-08
Primary Completion
2019-02-05
Completion
2019-02-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03920085 on ClinicalTrials.gov